Literature DB >> 11493477

Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation.

F M Stewart1, S Zhong, J F Lambert, G A Colvin, M Abedi, M S Dooner, C I McAuliffe, H Wang, C Hsieh, P J Quesenberry.   

Abstract

High levels of chimerism in syngeneic BALB/c transplants were reported when hosts were exposed to 1 Gy (100 cGy) whole body irradiation (WBI) and infused with 40 x 10(6) marrow cells. The recovery of host stem cells and alterations of enhanced host engraftability at varying times after 1 Gy WBI have now been evaluated in this study. Male BALB/c marrow (40 x 10(6) cells) was infused into female BALB/c hosts immediately or at 6, 12, and 24 weeks after 1 Gy WBI of host female BALB/c mice; engraftment percentages 8 weeks after cell injection at week 0, 6, 12, or 24 were 68% +/- 12%, 45% +/- 15%, 51% +/- 12%, or 20% +/- 8%, respectively. Eight-week engraftment levels in nonirradiated hosts average 7.7%. Conversely, engraftable stem cells measured at 8 weeks postengraftment in 1 Gy--exposed hosts were reduced to 8.6% +/- 3% of nonirradiated mice at time 0, 35% +/- 12% 6 weeks later, 49% +/- 10% at 3 months, and 21% +/- 7% at 6 months. Engraftment was still increased and stem cell decreased 1 year after 1 Gy. Furthermore, the primary cells transplanted into 1 Gy hosts can be serially transplanted, and the predominant effect of 1 Gy is directly on engrafting stem cells and not through accessory cells. These data show that transplantation in 1 Gy mice may be delayed until recovery of hematopoiesis, suggesting strategies in allogeneic transplantation to avoid the adverse effects of cytokine storm. The incomplete recovery of engraftable stem cells out to 12 months indicates that stem cell expansion, especially in patients previously treated with radiomimetic drugs, may not be feasible. (Blood. 2001;98:1246-1251)

Entities:  

Mesh:

Year:  2001        PMID: 11493477     DOI: 10.1182/blood.v98.4.1246

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Mobilization as a preparative regimen for hematopoietic stem cell transplantation.

Authors:  Jing Chen; André Larochelle; Simon Fricker; Gary Bridger; Cynthia E Dunbar; Janis L Abkowitz
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

2.  Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury.

Authors:  Rebecca L Porter; Mary A Georger; Olga Bromberg; Kathleen E McGrath; Benjamin J Frisch; Michael W Becker; Laura M Calvi
Journal:  Stem Cells       Date:  2013-02       Impact factor: 6.277

3.  Human Peripheral Blood Mononucleocyte Derived Myeloid Committed Progenitor Cells Mitigate H-ARS by Exosomal Paracrine Signal.

Authors:  Rishi Man Chugh; Payel Bhanja; Ximena Diaz Olea; Fang Tao; Kealan Schroeder; Ryan Zitter; Tanu Arora; Harsh Pathak; Bruce F Kimler; Andrew K Godwin; John M Perry; Subhrajit Saha
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

4.  Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation.

Authors:  Clas B Johansson; Sawsan Youssef; Kassie Koleckar; Colin Holbrook; Regis Doyonnas; Stephane Y Corbel; Lawrence Steinman; Fabio M V Rossi; Helen M Blau
Journal:  Nat Cell Biol       Date:  2008-04-20       Impact factor: 28.824

5.  Nonengraftment haploidentical cellular therapy for hematologic malignancies.

Authors:  John L Reagan; Loren D Fast; Eric S Winer; Howard Safran; James N Butera; Peter J Quesenberry
Journal:  Adv Hematol       Date:  2012-01-18

6.  The peripheral chimerism of bone marrow-derived stem cells after transplantation: regeneration of gastrointestinal tissues in lethally irradiated mice.

Authors:  Stanislav Filip; Jaroslav Mokrý; Jiřina Vávrová; Zuzana Sinkorová; Stanislav Mičuda; Pavel Sponer; Alžběta Filipová; Hana Hrebíková; Govindan Dayanithi
Journal:  J Cell Mol Med       Date:  2014-01-20       Impact factor: 5.310

7.  Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells.

Authors:  S Wen; M Dooner; Y Cheng; E Papa; M Del Tatto; M Pereira; Y Deng; L Goldberg; J Aliotta; D Chatterjee; C Stewart; A Carpanetto; F Collino; S Bruno; G Camussi; P Quesenberry
Journal:  Leukemia       Date:  2016-05-06       Impact factor: 11.528

8.  Cellular immunotherapy for refractory hematological malignancies.

Authors:  John L Reagan; Loren D Fast; Howard Safran; Martha Nevola; Eric S Winer; Jorge J Castillo; James N Butera; Matthew I Quesenberry; Carolyn T Young; Peter J Quesenberry
Journal:  J Transl Med       Date:  2013-06-19       Impact factor: 5.531

9.  Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium.

Authors:  Peter J Quesenberry; Jason Aliotta; Giovanni Camussi; Asim B Abdel-Mageed; Sicheng Wen; Laura Goldberg; Huang-Ge Zhang; Ciro Tetta; Jeffrey Franklin; Robert J Coffey; Kirsty Danielson; Vinita Subramanya; Ionita Ghiran; Saumya Das; Clark C Chen; Kae M Pusic; Aya D Pusic; Devasis Chatterjee; Richard P Kraig; Leonora Balaj; Mark Dooner
Journal:  J Extracell Vesicles       Date:  2015-08-28

10.  Low Doses of Oxygen Ion Irradiation Cause Acute Damage to Hematopoietic Cells in Mice.

Authors:  Jianhui Chang; Yi Luo; Yingying Wang; Rupak Pathak; Vijayalakshmi Sridharan; Tamako Jones; Xiao Wen Mao; Gregory Nelson; Marjan Boerma; Martin Hauer-Jensen; Daohong Zhou; Lijian Shao
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.